EXELIXIS, INC. (EXEL) Form SCHEDULE 13D/A — Nov 9, 2026
Farallon Capital Management filed Amendment No. 9 to its Schedule 13D on Exelixis, disclosing that the fund group's stake fell to 4.9% (12,017,906 shares) as of November 6, 2026, dropping below the 5% beneficial ownership threshold. The amendment's 60-day trading history shows near-continuous open-market selling from mid-October through early November 2026, including 568,000 shares sold on October 30 and 183,000 shares on November 6, at prices ranging from roughly $61 to $72.60.
Key figures
- Shares Outstanding
- 244010895
- Percent Owned
- 4.9%
- Sell Price Range
- $60.96-$72.60
- Amendment Number
- 9
- Shares Beneficially Owned
- 12017906
- Shares Sold Recent Sell Offs
- approximately 2.32M shares sold 10/14-11/6/2026
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.